Breaking News on Global Pharmaceutical Technology & Manufacturing

APIs (active pharmaceutical ingredients)

News headlines

The self-regulation society? Consultant challenges manufacturing status quo

15-Oct-2015 - API suppliers should be allowed to make process improvements without having to seek re-approval says consultant Girish Malhotra, who argues that the current rules create inefficiency and waste.

European API makers must invest to compete with India, says Infa Group

14-Oct-2015 - Clients are turning their backs on low-cost economies like India and returning to Infa Group, the Italian API maker says.

DSM's Nutritional Products team in Spain to sell vitamin APIs to drugmakers

13-Oct-2015 - DSM may have narrowed the focus of its pharmaceutical business in recent years, but the Netherlands-based supplier is still trying to win drug industry customers at a trade show in Spain.

It's not easy being green, but biotechs should consider it according to Piramal

13-Oct-2015 - Pharma and biotech firms not using ‘green chemistry’ to make their products incur higher costs and risk losing market share according to Piramal.

Hovione: API outsourcing not only about cost

12-Oct-2015 - The cost of outsourcing is far more than simply the price per kilogram of an API says Hovione, which is expanding a plant in New Jersey.

Live coverage of CPhI

The plaza to be: Medicine manufacturers meet in Madrid

12-Oct-2015 -   [View the story "Meds makers meet in Madrid " on Storify]

Chemical synthesis of IL-10 cytokine 90% cheaper than bioproduction, Provepep

08-Oct-2015 - Chemical synthesis of peptides and proteins can be done at a tenth of the cost of bioproduction says French chemistry specialist Provepep.


UK and India sign agreement to help ensure drug quality

05-Oct-2015 - The MHRA has signed a Memorandum of Understanding (MOU) with Indian regulators to help ensure the quality of drugs in the UK.

BASF new efficiency drive may involve job cuts

05-Oct-2015 - BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.

Biocon buys Vizag API plant from supplier Acacia

05-Oct-2015 - Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.

Pfizer hiring 40 at its Lipitor and Viagra API plants in Ireland

02-Oct-2015 - Over 40 new jobs will be created at Pfizer’s manufacturing sites in Cork, Ireland, including at a bulk Lipitor facility once earmarked for closure.

Johnson Matthey to take on all Pharmorphix staff

Johnson Matthey buys Sigma-Aldrich solid state chem unit to boost API business

01-Oct-2015 - Johnson Matthey has bought Sigma-Aldrich’s Pharmorphix division to add a 'significant' customer base and expand its European API business.

Pharmas factor green considerations into sourcing decisions say experts

30-Sep-2015 - Drug companies still outsource to cut costs but environmental concerns and therefore contractors’ green credentials are increasingly important say industry experts. 

US FDA rule: banned drugs will be destroyed

30-Sep-2015 - The FDA will begin destroying drugs which are refused entry to the US instead of returning them to their sender.

Catalloy fined after explosion at metal catalysts plant

29-Sep-2015 - A UK supplier of metal catalysts to the drug industry has been fined after an explosion at its site in Widnes left an employee with minor injuries.

Ashland to spin specialty chemicals business into standalone company

24-Sep-2015 - It will be business as usual for pharma customers as Ashland approves a plan to separate into two independent companies, the ingredients firm says.

India mulls reclassifying vitamins as drugs if they come with health claims

23-Sep-2015 - India may classify vitamin supplements as drugs rather than foods if the manufacturers of such products claim they can treat or prevent disease.

A reliable supply chain has never been more important, says Mylan CEO

23-Sep-2015 - Drugmakers need more certainty and reliabilty around their supply chain in light of increased regulatory vigilance says Mylan, itself carrying out remediation across several Indian facilities.


Indian firm reconstructing API plant after being slapped with USFDA warning

16-Sep-2015 - Indian API maker Pan Drugs is reconstructing its manufacturing suite after holes in the wall and rusty equipment landed the facility a US FDA warning.

Biocon launches insulin pen, fully 'made in India' from new device plant

16-Sep-2015 - Biocon has begun commercial manufacturing at its Bangalore devices facility to support the launch of its insulin pen product, Basalog One.

Related News

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation